Beilloso Facial Bump Refining Essence

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the improvement of skin texture through gentle exfoliation. It is designed to aid in the smoothing of the skin, making it suitable for individuals seeking to enhance the overall appearance and feel of their skin.

Dosage and Administration

The essence should be applied daily after cleansing and toning of the skin. For optimal results, it is recommended to use the essence twice a day for a minimum duration of 4 weeks.

A pea-sized amount of the essence should be dispensed onto the affected area. The product should then be gently massaged into the skin using the fingertips until fully absorbed. Continued use is advised until the appearance of skin papules is no longer observed.

Contraindications

Use is contraindicated in children under 2 years of age due to the potential for adverse effects. Additionally, application on open skin wounds is not recommended, as it may lead to complications or hinder the healing process.

Warnings and Precautions

For external use only. It is imperative to discontinue use and consult a healthcare professional if any rash or irritation develops.

In children under the age of 2 years, caution is advised. The product should not be applied to open skin wounds, as this may increase the risk of adverse effects.

Should irritation or rash occur, it is essential to stop using the product immediately and seek medical advice.

In the event of accidental ingestion, prompt medical assistance is required. Contact the Poison Control Center or seek emergency medical help without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event of rash or irritation, it is advised to discontinue use and consult a healthcare professional.

Participants in clinical settings have reported that irritation or rash may occur, necessitating the same recommendation to stop use and seek medical advice. It is important for patients to monitor their skin's response to the product and act accordingly if any adverse reactions arise.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Beilloso Facial Bump Refining Essence (salicylic acid 1% facial bump refining essence). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this medication. It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of Beilloso Facial Bump Refining Essence during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should exercise caution and consider the lack of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, including airway management, oxygen supplementation, and intravenous fluids.

If the specific agent involved in the overdose is known, appropriate antidotes or treatments should be administered as per established guidelines. Continuous monitoring of the patient’s condition is crucial, and further interventions may be required based on the evolving clinical picture.

It is advisable for healthcare professionals to consult local poison control centers or toxicology experts for guidance on managing specific overdose cases. Documentation of the incident and any interventions performed is also critical for ongoing patient care and legal considerations.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should seek medical help or contact the Poison Control Center immediately.

It is important to inform patients that this medication should not be used in children under 2 years of age or on open skin wounds. Patients should be counseled to discontinue use and consult a doctor if they experience any irritation or rash.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes, ears, mouth, and any open or broken skin areas while using the medication. In the event of contact with the eyes, patients should be instructed to rinse their eyes thoroughly with water.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, shady place to maintain its integrity and effectiveness. Proper storage conditions are crucial to ensure the product remains within the recommended temperature range and is protected from direct sunlight and excessive heat.

Additional Clinical Information

The product is administered topically, with a recommended application frequency of once daily after cleansing and toning, or twice daily for a minimum duration of four weeks. Clinicians should counsel patients that the product is for external use only. Patients are advised to discontinue use and consult a physician if rash or irritation occurs. In case of contact with eyes, thorough rinsing with water is necessary. The product should be kept out of reach of children, and if ingested, medical assistance or contact with the Poison Control Center is recommended.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Beilloso Facial Bump Refining Essence, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)